<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01344213</url>
  </required_header>
  <id_info>
    <org_study_id>anesTKA08</org_study_id>
    <nct_id>NCT01344213</nct_id>
  </id_info>
  <brief_title>Pregabalin, Celecoxib, Total Knee Arthroplasty and Intrathecal Morphine</brief_title>
  <acronym>PCTKA</acronym>
  <official_title>Comparison of Analgesic Efficacy Among Pregabalin, Celecoxib, Pregabalin With Celecoxib and Placebo After Total Knee Arthroplasty Under Intrathecal Morphine</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chulalongkorn University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bhumibol Adulyadej Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>King Chulalongkorn Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chulalongkorn University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate whether pregabalin and/or celecoxib could improve analgesic efficacy of
      intrathecal morphine for patients after total knee arthroplasty.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A single-dose spinal anesthesia combining with morphine for total knee arthroplasty (TKA) is
      a simple, economical anesthetic technique commonly used in our hospital. Still some patients
      could not get effective postoperative pain control. Pregabalin, an anticonvulsant, has been
      shown to reduce acute pain after molar extraction, laparoscopic cholecystectomy, and reduce
      postoperative morphine requirement after total hip arthroplasty, and celecoxib, a selective
      cyclo-oxygenase (COX) - 2 inhibitor, with perioperative prescription is successfully reduces
      pain score and opioid consumption after TKA under spinal anesthesia alone. However, no
      clinical study has yet investigated whether preoperative single-dose of pregabalin, celecoxib
      or in combination compared to placebo can improve analgesic efficacy of intrathecal morphine
      after TKA. The primary objective of this study was to evaluate whether these medications
      could reduce pain scores at rest / when movement and morphine requirement after TKA under
      spinal anesthesia with intrathecal morphine. Secondary outcome assessed include adverse
      effects, anxiety score and patients' satisfaction score.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>July 2008</start_date>
  <completion_date type="Actual">October 2010</completion_date>
  <primary_completion_date type="Actual">October 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>24-hour cumulative morphine consumption</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
    <description>The time to first morphine requirement will be recorded
The cumulative morphine consumption will be recorded at the end of surgery and 2-h, 6-h, 10-h, 24-h, and 48-h postoperatively
Visual analog scale (VAS) pain scores at rest will be assessed at the night before surgical date, before starting anesthesia, at the end of surgery, and 2-h, 6-h, 10-h, 24-h and 48-h postoperatively
Visual analog scale (VAS) pain scores when on movement will be assessed at the end of surgery, and 2-h, 6-h, 10-h, 24-h and 48-h postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Anxiety scores (VAS), patients' satisfaction</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 2 weeks</time_frame>
    <description>Anxiety scores will be assessed at the night before surgical date, before starting anesthesia, at the end of surgery, and 2-h, 6-h, 10-h, 24-h and 48-h postoperatively;
24-h and 48-h patients' satisfaction (0-10,0=dissatisfied and 10= very satisfied)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Postoperative Pain Management</condition>
  <condition>Total Knee Arthroplasty</condition>
  <arm_group>
    <arm_group_label>Pregabalin</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral single-dose of pregabalin (150 mg) and 1 capsule of placebo (P) 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Celecoxib</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral single-dose of celecoxib (400 mg) and 1 capsule of placebo (C) 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregabalin with celecoxib</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Oral single-dose of pregabalin (150 mg) and celecoxib (400 mg) (PC) 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Oral single-dose of placebo 2 capsules 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin</intervention_name>
    <description>Oral single-dose of pregabalin (150 mg) and placebo (P) 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.</description>
    <arm_group_label>Pregabalin</arm_group_label>
    <other_name>Pregabalin: Lyrica</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Celecoxib</intervention_name>
    <description>Oral single-dose of celecoxib (400 mg) and placebo(C)1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.</description>
    <arm_group_label>Celecoxib</arm_group_label>
    <other_name>Celecoxib: Celebrex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pregabalin with celecoxib</intervention_name>
    <description>Oral single-dose of pregabalin (150 mg) and celecoxib (400 mg) (PC) 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg.</description>
    <arm_group_label>Pregabalin with celecoxib</arm_group_label>
    <other_name>Pregabalin: Lyrica</other_name>
    <other_name>Celecoxib: Celebrex</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Oral single dose of placebo 2 capsules 1-2 hours before starting spinal anesthesia with intrathecal morphine 0.2 mg</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Placebo: sugar capsule</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients between 50-75 years of age

          -  Patients with an American Society of Anesthesiologists physical status of I to III

          -  Patients scheduled for primary TKA with a diagnosis of osteoarthritis under spinal
             anesthesia

        Exclusion Criteria:.

          -  Patients had a known allergy to any of the medications being used

          -  a history of drug or alcohol abuse

          -  a history of taking chronic pain medications (ie, show-release preparations of
             opioids, given that morphine consumption was the primary outcome)

          -  a history of taking pregabalin or gabapentin / non-steroidal anti-inflammatory drugs /
             COX-2 inhibitors

          -  a psychiatric disorder

          -  a history of impaired renal function (Cr &gt; 1.5 mg/dl), peptic ulcer, asthma,
             thrombotic cerebrocardiovascular diseases, uncontrolled hypertension

          -  a history of contraindication for spinal anesthesia

          -  a history of bleeding tendency

          -  pregnancy

          -  unable or unwilling to use patient - controlled analgesic (PCA)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Supranee Niruthisard, BSc, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>King Chulalongkorn Memorial Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Supranee Niruthisard</name>
      <address>
        <city>Bangkok</city>
        <zip>10330</zip>
        <country>Thailand</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 26, 2011</study_first_submitted>
  <study_first_submitted_qc>April 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2011</study_first_posted>
  <last_update_submitted>August 2, 2011</last_update_submitted>
  <last_update_submitted_qc>August 2, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 4, 2011</last_update_posted>
  <responsible_party>
    <name_title>Assoc.Professor Supranee Niruthisard</name_title>
    <organization>Department of Anesthesiology, Faculty of Medicine, Chulalongkorn Unv.</organization>
  </responsible_party>
  <keyword>Pregabalin</keyword>
  <keyword>Celecoxib</keyword>
  <keyword>Intrathecal morphine</keyword>
  <keyword>Total knee arthroplasty</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Pregabalin</mesh_term>
    <mesh_term>Celecoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

